Showing 35,231 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Access to healthcare

Dolutegavir access in the Asia-Pacific region

Editor's pick
amfAR Treat Asia
27 June 2017
Drug policy & policing

Why opioid deaths are this generation’s Aids crisis

Editor's pick
The Guardian
27 June 2017
Hepatitis C treatment

Charity calls for new focus to combat Hep C infections in Scotland

Editor's pick
BBC
27 June 2017
Ageing & HIV

I've grown old with HIV. I don't fear the virus any more, I fear the stigma

Editor's pick
The Guardian
27 June 2017
Global health initiatives

The gospel according to Mark Dybul, the man working to end three plagues

Editor's pick
Devex
26 June 2017
Hepatitis C treatment

Swiss hepatitis C sufferers to get full access to expensive drug

Editor's pick
swissinfo.ch
26 June 2017
New & experimental hepatitis C treatment

New pangenotypic hepatitis C drug combinations recommended for approval in the European Union

News
26 June 2017
HIV & criminal law

Charlie Sheen sued again for allegedly exposing ex to HIV

Editor's pick
New York Daily News
26 June 2017
Epidemiology

Fall in new HIV diagnoses among men who have sex with men (MSM) at selected London sexual health clinics since early 2015: testing or treatment or pre-exposure prophylaxis (PrEP)?

Editor's pick
Eurosurveillance
26 June 2017
New & experimental hepatitis C treatment

European CHMP Adopts Positive Opinion for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes

Editor's pick
Gilead press release
26 June 2017
Finance & funding

In Venezuela, a once-leading AIDS program lies in ruins

Editor's pick
Globe & Mail
26 June 2017
PrEP

Call for HIV drug to be made available to stem epidemic

Editor's pick
Irish Times
26 June 2017
New & experimental hepatitis C treatment

AbbVie Receives CHMP Positive Opinion for MAVIRET™ (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)

Editor's pick
AbbVie press release
26 June 2017
People who inject drugs

Covering America's 'testing ground' for responses to drug use, HIV risk

Editor's pick
Columbia Journalism Review
26 June 2017
Retention & linkage to care

Malawi: Study finds fear drives pregnant women with HIV from prevention services

Editor's pick
Science Speaks
26 June 2017
Global health targets

Many Western European countries close to achieving UNAIDS 90-90-90 targets

News
25 June 2017
Epidemiology

Fall in HIV among gay men could spell end for Britain's epidemic, say experts

Editor's pick
The Guardian
22 June 2017
Global health targets

In East Africa, Universal HIV Testing and Treatment Surpasses UNAIDS Goals

Editor's pick
UCSF News Services
22 June 2017
PrEP

Sex without fear – ​my experiment with ​the HIV-prevention drug PrEP

Editor's pick
The Guardian
22 June 2017
Cardiovascular disease

HIV has a similar impact to diabetes on heart disease risk

News
21 June 2017
The search for a cure

Last Gift Study: Community Perspective on End-of-Life HIV Research

Editor's pick
Infectious Disease Advisor
21 June 2017
The search for a cure

Last Gift Study: End-of-Life HIV Research

Editor's pick
Infectious Disease Advisor
21 June 2017
Transgender people

How doctors in Texas are trying to protect transgender patients from a persistent threat: HIV

Editor's pick
Los Angeles Times
21 June 2017
History of HIV & AIDS

‘Fathers’ Explores a World Where AIDS Never Killed Our Queer Forbearers (Video)

Editor's pick
Unicorn Booty
21 June 2017